An illegal and experimental weight-loss drug is spreading in the Netherlands, according to De Telegraaf. The newspaper reported on Monday, 19 October 2026, that the unapproved product is gaining a foothold in the country. Its coverage carries a blunt warning from someone familiar with the risk: using it amounts to gambling with your own life.
De Telegraaf describes the substance as both illicit and still at the experimental stage, meaning it has not gone through the checks that would make it a legitimate treatment. The report does not name the drug or specify where in the Netherlands it has been found. What it does make clear is that people are turning to a product that sits outside the regulated medicines system.
The headline itself signals the paper's framing: a market for something unproven is expanding, and the consequences fall on the people taking it. The quoted warning — that users are effectively playing with their lives — is the central message of the report.
Details remain thin. De Telegraaf has not, in the material available, identified the drug's composition, its source, or how widely it has circulated. Nor has it reported any confirmed cases of harm. Those gaps matter, because the scale of the problem is still unclear.
What to watch next: whether Dutch health authorities respond to the report, and whether further reporting identifies the product or the channels through which it is being sold.
